Navigation Links
Medarex to Present at the Bank of America 2008 Healthcare Conference
Date:5/6/2008

PRINCETON, N.J., May 6 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the Bank of America 2008 Healthcare Conference at 1:00 p.m. EDT on Tuesday, May 13, 2008. The event will be webcast live and will be available in the Investor Relations section of the Medarex website at http://www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., , ST. LOUIS, Nov. 24 /PRNewswire-First...) will be presenting at the NASDAQ OMX conference ... 7:45 AM US/CST. Interested parties may listen via...at http://inve s tor.sig m a a ldrich.com/...this file. ,, About Sigma-Aldrich: Sigma-...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-...ate Food & Drug Administration (SFDA) has appr...) for its oral insulin project,(Nodlin), an innova...ND,approval allows Biolaxy to initiate its first p...sorder characteristic of high blood glucose and po...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
(Date:11/24/2009)... Chemical Abstracts Servic..., reports that China,s patent office is now the wo...tions in chemistry. China trailed Japan,s patent o...n (WIPO), and the United States Patent and Tradema...ed the USPTO in 2005, WIPO in 2006, and exceeded J...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...(Nasdaq: VRUS ) management will present at the 3r...2008, at the Citi Executive Conference Center, New...gan Stanley Global,Healthcare Unplugged Conference...ew York, NY. Schaefer Price, Pharmasset,s Chief Ex...he company followed by a question and,answer sessi...
...ESMO Congress,in Stockholm, the premier European c... medical oncologists, as well as a focal point to ...nes., The Congress Centre will be the venue for i...nd a place to discuss critical issues for,European...raining of young,oncologists and better integratio...
...rstCall/ -- Huifeng Bio-,Pharmaceutical Technology... leading developer and producer of plant extracts ...ceutical, nutraceutical and food production in,Xi,...nt to enter into a,contractual arrangement with Xi...e proposed terms of this arrangement, Huifeng will...
Other Biology Technology:Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2
(Date:11/24/2009)... been prescribed by traditional healers in Brazil ...omach pain to fever and flu. , Now for the first ...n able to scientifically prove the pain relieving ... Brazilian mint. , Testing this ancient South Ame...ciela Rocha was able to show that when prepared as...
(Date:11/24/2009)...remarkable class of ring-shaped protein motors has...erkeley National Laboratory (Berkeley Lab) using a... at the Advanced Light Source (ALS). These protein...replication, and are vital to the survival of all ...ch as the human papillomavirus, which has been lin...
(Date:11/24/2009)...2009) New research on bacterial communities throu...edictable temporal patterns, suggesting that scien...onitoring climate change in the polar regions. The... the National Academy of Sciences Early Edition, ... shifted synchronously over time, correlating with...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 1Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 2Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year 53045 3MUSA Technology Partners Introduces Linux Open Source Service Desk 13245 1MUSA Technology Partners Introduces Linux Open Source Service Desk 13245 2MUSA Technology Partners Introduces Linux Open Source Service Desk 13245 3American Academy of Dermatology to Hold Summer Scientific Meeting in Boston 53038 1
...archer at the Hebrew University of Jerusalem has s...urons in the brain of a mammal. , Dr. Adi Mizrahi...r Silberman Institute of Life Sciences at the Hebr...ons, or nerve cells, develop from an undifferentia...This has great significance for the future of brai...
... a new gene therapy can nearly eliminate arthritis...o the affected joints, according to a study publis... While the study was done in mice, they are the fi...is like humans, with the same genetic predispositi...ase, the authors said. If all goes well with a fol...
...k could soon be roaming our pastures, reports Cath...ine of the SCI. Scientists in New Zealand have di...a natural ability to produce skimmed milk and plan... producing only skimmed milk. , The researchers a...with the unique characteristics required to make a...
Other Biology News:A first -- Hebrew University scientist observes brain cell development in 'real time' 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4Skimmed milk -- Straight from the cow 2
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
Custom siRNA, standard purity, annealed from Ambion
...ed to rapidly and reliably amplify unknown genomic...rovides hassle-free, ready-to use components, at a... ingredients are provided in each kit. The Genome ... cloning of genomic DNA, isolating promoter and re...
Bis-acrylamide, Ultra Pure from Research Organics, Inc.
Biology Products: